Elan's shareholders approved the Irish firm's pending purchase by Perrigo for $8.6 billion. The acquisition could be finalized this year.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||